featured
Postoperative Trial of Platinum-Based Chemotherapy vs Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131
J. Clin. Oncol 2021 Jun 06;[EPub Ahead of Print], IA Mayer, F Zhao, CL Arteaga, WF Symmans, BH Park, BL Burnette, AJ Tevaarwerk, SF Garcia, KL Smith, DF Makower, M Block, KA Morley, CR Jani, C Mescher, SJ Dewani, B Tawfik, LE Flaum, EL Mayer, WM Sikov, ET Rodler, LI Wagner, AM DeMichele, JA Sparano, AC Wolff, KD MillerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.